Methods for treating familial adenomatous polyposis
US10945981B2 · kind B2 · utility
1Cited by
21References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2020 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | May 15, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for preventing or delaying the need for surgical intervention in a patient having familial adenomatous polyposis (FAP) and an at least partially intact lower gastrointestinal tract. Also provided are methods for preventing or delaying the formation of neoplasia and/or cancer in a patient having FAP. The methods comprise administering an effective amount of a pharmaceutical therapy that comprises eflornithine and sulindac to a patient having FAP and an intact lower gastrointestinal tract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.